[The surgical experiences and risk factors of combined valvular procedure and myocardial revascularization]

Q Wu1, Q Meng, S Hu

  • 1Department of Cardiovascular Surgery, Fu Wai Hospital, PUMC & CAMS, 100037, China.

Zhonghua Yi Xue Za Zhi
|January 19, 2002
PubMed

Insights

Combined valve surgery and coronary artery bypass grafting (CABG) can improve heart function but increases operative mortality. Key success factors include complete revascularization and effective myocardial protection.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Valve Surgery
  • Coronary Artery Bypass Grafting

Context:

  • The study examines the combined procedure of valve surgery and CABG.
  • A cohort of 76 patients (61 men, 15 women; mean age 56) underwent this combined procedure.
  • The primary etiologies were rheumatic disease (67 patients) and degenerative valve disease (9 patients).

Purpose:

  • To report the experience and outcomes of combined valve procedures and CABG.
  • To analyze risk factors associated with operative mortality in this patient group.

Summary:

  • The combined procedure involved various valve interventions (AVR, MVR, BVR, MVP) alongside CABG.
  • Operative mortality was 7.89% (6 deaths).
  • Follow-up in 63 survivors showed significant improvement in cardiac function for 62 patients.

Impact:

  • Combined valve replacement/repair with CABG generally increases operative mortality.
  • Preoperative myocardial infarction, NYHA class IV, lower ejection fraction (EF), and longer cardiopulmonary bypass (CPB) and aortic clamping times are linked to hospital mortality.
  • Successful outcomes depend on complete grafting of coronary lesions, restored valvular function, and robust myocardial protection.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...